This site is intended for healthcare professionals only
Coronavirus
Filter:
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
Diabetes Distilled: Who DAREs wins. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19
DARE-19: Dapagliflozin safe and effective for non-critically ill people with COVID-19.
4 Aug 2021